Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 9
2003 9
2004 12
2005 10
2006 9
2007 9
2008 5
2009 8
2010 16
2011 10
2012 12
2013 13
2014 11
2015 7
2016 5
2017 6
2018 14
2019 17
2020 6
2021 11
2022 9
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone.
Kanao K, Takahashi T, Umezawa Y, Okabe T, Kaneko G, Shirotake S, Nishimoto K, Oyama M. Kanao K, et al. Among authors: takahashi t. PLoS One. 2022 Oct 20;17(10):e0276081. doi: 10.1371/journal.pone.0276081. eCollection 2022. PLoS One. 2022. PMID: 36264927 Free PMC article.
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib.
Nishimoto K, Shirotake S, Miyama Y, Kaneko G, Kanao K, Igarashi D, Takahashi T, Umezawa Y, Yasuda M, Oyama M. Nishimoto K, et al. Among authors: takahashi t. IJU Case Rep. 2022 Feb 18;5(3):149-152. doi: 10.1002/iju5.12422. eCollection 2022 May. IJU Case Rep. 2022. PMID: 35509782 Free PMC article.
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma.
Murakami T, Kikuchi E, Ide H, Umezawa Y, Takahashi T, Izawa M, Hakozaki K, Shigeta K, Ogihara K, Kobayashi H, Kanai K, Maeda T, Yoshimine S, Mizuno R, Nishimoto K, Oya M. Murakami T, et al. Among authors: takahashi t. BJUI Compass. 2021 Mar 9;2(5):322-330. doi: 10.1002/bco2.81. eCollection 2021 Sep. BJUI Compass. 2021. PMID: 35474877 Free PMC article.
197 results